STAT5B and chronic myelogenous leukemia, BCR-ABL1 positive: The FDA-approved neuroleptic agent Pimozide was identified in a high-throughput screen as an inhibitor of STAT5 phosphorylation and an inducer of apoptosis in CML cell lines [149].